Status:
COMPLETED
Guardant360® Related Clinical Outcomes in Patients Who Share Medical Records-Breast Cancer
Lead Sponsor:
Guardant Health, Inc.
Conditions:
Advanced Breast Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to observe the routine clinical care of patients who have been diagnosed with breast cancer and have undergone Guardant360 testing.
Detailed Description
Patients who have been diagnosed with breast cancer and have undergone Guardant360 testing will be approached regarding participation in the study. After being informed about the study and potential r...
Eligibility Criteria
Inclusion
- Adults (18 years of age and older) with a diagnosis of breast cancer
- Guardant360 test results released to the patient's physician no less than 14 days prior to initial patient contact
- Patient has previously provided contact information (either email or phone) to Guardant Health
- Able and willing to complete the electronic informed consent process
- Must have access to a computer terminal or personal computing device
- Willingness to consent to the release of medical records
Exclusion
- 1\. Unable to understand English
Key Trial Info
Start Date :
July 2 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 17 2022
Estimated Enrollment :
109 Patients enrolled
Trial Details
Trial ID
NCT04436393
Start Date
July 2 2020
End Date
March 17 2022
Last Update
June 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Guardant Health
Redwood City, California, United States, 94063